Technology.
We invest in technologies that will underpin the global economy of tomorrow, ranging across new energy, biotechnology, and automotives.
Investing in tomorrow.
ASF's technology investments span two areas — new energy powertrain engineering through SYTECH, and cell-based tissue engineering through its investment in BSF Enterprise PLC, listed on the London Stock Exchange.
NEW ENERGY
SYTECH Engines
SYTECH Powertrain Technologies Co., Ltd is dedicated to the development of New Energy technologies. With the support of FEV Germany, SYTECH has developed an innovative modular family of internal combustion engines capable of operating on gasoline, LPG, CNG, and hydrogen.
LIFE SCIENCES
BSF Enterprise PLC
BSF Enterprise PLC (LON: BSFA) is a UK-listed biotechnology company focused on developing and commercialising cell-based tissue engineering solutions. Through its subsidiary 3D Bio-Tissues, BSF is developing lab-grown corneas, cultivated meat, lab-grown leather, and skin substitutes.
A modular new energy engine family.
SYTECH Powertrain Technologies Co., Ltd is dedicated to the development of New Energy engine technologies. The SYTECH engine has been designed and developed by Australian engineers with the support of FEV Germany — one of the world's leading independent engineering service providers for the development of powertrain systems.
The engine is a modular design covering different displacements and power outputs from 30kW to 250kW, capable of operating on gasoline, LPG, CNG, and hydrogen. This multi-fuel flexibility allows SYTECH engines to co-exist with battery electric vehicles in the transition to zero-emission mobility — functioning as a range extender on gasoline or CNG today, and transitioning to hydrogen as infrastructure matures.
Production of the first 4-cylinder 1.5L turbocharged engine — intended for use in Range Extended Electric Vehicles — is scheduled to commence in China. The engine employs many common parts to lower cost, has a flat efficiency curve over its operating speed range, and delivers low noise and vibration across all fuel types.
Thermal efficiency
Over 35.3% between 2000–4200 rpm, with a minimum BSFC of less than 229 g/kWh achieved at 37% thermal efficiency at 13 bar BMEP
Rated power output
110 kW at 4,500 rpm with peak torque of 234 Nm from 2,500 to 4,500 rpm
Durability testing
Over 500 hours of combustion and durability testing completed across the 4-cylinder 1.5L TC engine
Emissions compliance
Achieves Euro 6d and China 6b regulations. Range Extended Vehicle configuration expected to meet proposed Euro 7 legislation
Engine design
Opposed 4-cylinder (boxer-type) crankshaft, conrod, and piston arrangement — enabling low centre of gravity and reduced vibration
Developed with FEV Germany
FEV Group is one of the world's leading independent engineering service providers for the development of powertrain systems. FEV's involvement as engineering partner provides SYTECH with globally recognised technical validation as the engine moves towards full commercialisation.
4-cylinder 1.5L TC — current engine
Performance test results.
110 kW
Rated power at 4,500 rpm
234 Nm
37%
<229 g/kWh
Rated power at 4,500 rpm
500+ hrs
Euro 6d
Testing highlights
Flat efficiency curve maintained from 2,000 to 4,200 rpm, enabling consistent performance across the full operating speed range
Low vibration and noise compared to existing production vehicles — validated through independent durability testing
Range Extended Vehicle configuration meets Euro 6d / China 6b and is expected to satisfy proposed future Euro 7 emissions legislation
Designed to operate on gasoline, LPG, CNG, or hydrogen — providing a clear pathway from today's fuels to a hydrogen-powered future
Low fuel consumption across all fuel types with low to zero emissions when operating on hydrogen
Common parts strategy across the engine family reduces manufacturing cost and simplifies supply chain management
Modular platform.
The SYTECH engine family is built on a modular platform with high commonality of components across all variants, reducing cost and simplifying production. All configurations support the full range of fuel types.
SYTECH 0.8L
800cc · 2-cylinder
30–55 kW
Power output range
SYTECH 1.5L TC
1,500cc · 4-cylinder turbocharged
65–110 kW
Power output range
SYTECH 3.0L
3,000cc · 8-cylinder
130–250 kW
Power output range
Designed for multiple use cases.
🚗
Range Extended Electric Vehicles
BEV with SYTECH gasoline range extender generator meeting Euro 6d / China 6b
⚡
🏠
🚢
BSF Enterprise PLC —
cell-based tissue engineering.
ASF Group holds an interest in BSF Enterprise PLC (LON: BSFA), a UK-listed biotechnology company focused on developing and commercialising cell-based tissue engineering solutions. BSF operates through its wholly-owned subsidiary 3D Bio-Tissues (3DBT), a clinical and cellular agriculture company headquartered in the United Kingdom.
BSF's technology platform is built around scaffold-free cell-based tissue engineering — a process that cultivates living cells to produce human and animal tissues without the use of synthetic scaffolding. This core technology underpins three distinct commercial strands across healthcare, food technology, and sustainable materials.
ASF's interest in BSF reflects the Group's broader strategy of identifying and supporting early-stage technology companies with global commercial potential.
LON:BSFA
BSF Enterprise PLC is listed on the London Stock Exchange.
3D Bio-Tissues (3DBT)
Wholly-owned subsidiary producing lab-grown human corneas, cultivated meat, and cell culture media. City-Mix™ is an animal-free cell growth agent for skin, muscle, and fat cell cultivation.
Kerato (Keratox™)
Focused on lab-grown human corneal tissue and ocular toxicity testing — addressing a global shortage of donor corneas that affects millions of patients.
BSF Enterprise (Hong Kong)
Facilitates commercial partnerships and fundraising across the Asian market, including cultivated meat commercialisation in China through a partnership with Ivy Farm.